JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
RNA Research Solutions

RNA Research Solutions

R1039 EZ Cap™ Human P16 mRNA (ψUTP)

Summary: Human p16 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1040 EZ Cap™ Human P16 mRNA (5-moUTP)

Summary: Human p16 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1041 EZ Cap™ Mouse P16 mRNA

Summary: Mouse p16 mRNA with Cap 1 structure, providing high transcriptional efficiency
R1042 EZ Cap™ Mouse P16 mRNA (ψUTP)

Summary: Mouse p16 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1043 EZ Cap™ Mouse P16 mRNA (5-moUTP)

Summary: Mouse p16 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
B8155 Biotin-11-UTP

Summary: A biotin-labeled nucleotide analog, used to form labeled RNA

Soluble in DMSO
C1042 SM-102
4 Citation

insoluble in DMSO; ≥175.8 mg/mL
B8595 ALC-0315

Summary: ALC-0315 is an ionizable amino lipid that can be combined with other lipids to form lipid nanoparticles (LNP). LNP containing ALC-0315 can be utilized for the delivery of mRNA vaccines.

≥59.3 mg/mL
B8596 ALC-0159

Summary: ALC-0159 is a lipid excipient. ALC-0159-containing formulation have been used to develop lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines.

≥39.4 mg/mL
R1021 EZ Cap™ Renilla Luc mRNA

Summary: Renilla Luc mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.